NCT01788553View on ClinicalTrials.gov

Study Of Remission In Patients Treated For Generalized Anxiety Disorder

CompletedOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2007

Conditions
Anxiety Disorders
Interventions
OTHER

remission prevalence of generalized anxiety disorder

Trial Locations (1)

Unknown

Pfizer Inc., Brussels

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT01788553 - Study Of Remission In Patients Treated For Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter